Light Mode
$8.10 ↑ +0.00 (+0.00%) Trading Up from the previous close of $8.10, $0.45 below the day’s high of $8.55
-5.15 (-38.87%) / 6M
Momentum, market sentiment, and recent alerts
ETRA reads poor: the 12-month move is -38.9%.
No alerts for ETRA in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.